EP3023816A1 — Composition for manufacturing optical device having negative optical dispersion and optical anisotropic body manufactured therefrom
Assigned to LG Chem Ltd · Expires 2016-05-25 · 10y expired
What this patent protects
The present invention relates to a composition for manufacturing optical elements with negative optical dispersion, and an optically anisotropic body prepared therefrom. According to the present invention, the optically anisotropic body showing stable reverse wavelength dispersio…
USPTO Abstract
The present invention relates to a composition for manufacturing optical elements with negative optical dispersion, and an optically anisotropic body prepared therefrom. According to the present invention, the optically anisotropic body showing stable reverse wavelength dispersion can be prepared more simply by using the composition for optical elements, and it is possible to apply the same to liquid crystal display devices as an optical film such as a thin-layer broadband »/4 plate.
Drugs covered by this patent
- Journavx (SUZETRIGINE) · Vertex Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.